Michael M. Abecassis's most recent trade in PharmaCyte Biotech Inc was a trade of 38,009 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on April 30, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| PharmaCyte Biotech Inc | Michael M. Abecassis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2024 | 38,009 | 38,009 | - | - | Stock Option (Right to Buy) |